X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (966) 966
Publication (122) 122
Book Review (14) 14
Dissertation (5) 5
Book Chapter (2) 2
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (780) 780
moraxella catarrhalis - drug effects (740) 740
haemophilus influenzae - drug effects (543) 543
microbial sensitivity tests (465) 465
streptococcus pneumoniae - drug effects (441) 441
anti-bacterial agents - pharmacology (401) 401
microbiology (353) 353
moraxella catarrhalis - isolation & purification (306) 306
infectious diseases (296) 296
respiratory tract infections - microbiology (265) 265
pharmacology & pharmacy (245) 245
male (241) 241
haemophilus influenzae - isolation & purification (229) 229
female (222) 222
streptococcus pneumoniae - isolation & purification (197) 197
index medicus (189) 189
child, preschool (185) 185
streptococcus-pneumoniae (173) 173
drug resistance, microbial (171) 171
child (170) 170
moraxella catarrhalis (156) 156
infant (154) 154
adult (140) 140
anti-bacterial agents - therapeutic use (138) 138
drug resistance, bacterial (136) 136
haemophilus-influenzae (136) 136
respiratory tract infections - drug therapy (129) 129
staphylococcus aureus - drug effects (120) 120
middle aged (113) 113
moraxella catarrhalis - enzymology (113) 113
aged (109) 109
streptococcus pneumoniae (109) 109
haemophilus influenzae (105) 105
resistance (103) 103
susceptibility (103) 103
acute disease (100) 100
antibiotics (100) 100
adolescent (97) 97
branhamella-catarrhalis (88) 88
children (88) 88
bacteria (85) 85
streptococcus pyogenes - drug effects (84) 84
anti-infective agents - pharmacology (83) 83
bacteria - drug effects (82) 82
fluoroquinolones (82) 82
otitis media - microbiology (82) 82
immunology (81) 81
nasopharynx - microbiology (77) 77
community-acquired infections - microbiology (76) 76
cephalosporins - pharmacology (75) 75
moraxella-catarrhalis (75) 75
antimicrobial resistance (72) 72
pediatrics (71) 71
united-states (70) 70
research article (69) 69
acute otitis-media (68) 68
haemophilus infections - drug therapy (68) 68
infections (68) 68
penicillin resistance (68) 68
beta-lactamases - metabolism (67) 67
animals (66) 66
bacterial infections - drug therapy (63) 63
otitis media - drug therapy (63) 63
pathogens (63) 63
prevalence (63) 63
haemophilus influenzae - enzymology (62) 62
respiratory tract infections - epidemiology (62) 62
bacterial infections - microbiology (61) 61
moraxella catarrhalis - genetics (59) 59
pneumonia (59) 59
surveillance (59) 59
haemophilus infections - microbiology (57) 57
moraxellaceae infections - microbiology (55) 55
otitis media (54) 54
erythromycin - pharmacology (53) 53
neisseriaceae infections - drug therapy (53) 53
neisseriaceae infections - microbiology (53) 53
beta-lactamases - biosynthesis (52) 52
aged, 80 and over (51) 51
amoxicillin - pharmacology (51) 51
administration, oral (49) 49
anti-bacterial agents - administration & dosage (49) 49
staphylococcus aureus - isolation & purification (47) 47
macrolides (46) 46
prospective studies (46) 46
levofloxacin (45) 45
moraxella catarrhalis - growth & development (45) 45
penicillin (45) 45
streptococcus - drug effects (45) 45
antimicrobial susceptibility (43) 43
oncology (43) 43
otorhinolaryngology (43) 43
pneumococcal infections - drug therapy (43) 43
health aspects (42) 42
pseudomonas aeruginosa - drug effects (42) 42
bacterial pneumonia (41) 41
klebsiella pneumoniae - drug effects (41) 41
time factors (41) 41
community-acquired infections - drug therapy (40) 40
sputum - microbiology (40) 40
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (872) 872
Japanese (40) 40
French (18) 18
Spanish (10) 10
Chinese (9) 9
Polish (7) 7
German (5) 5
Russian (4) 4
Croatian (3) 3
Italian (2) 2
Portuguese (2) 2
Dutch (1) 1
Korean (1) 1
Romanian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 7/2009, Volume 49, Issue 1, pp. 124 - 131
Moraxella catarrhalis is an exclusively human pathogen and is a common cause of otitis media in infants and children, causing 15%-20% of acute otitis media... 
Pathogens | Vaccination | Clinical Practice | Otitis media | Moraxella catarrhalis | Bacteria | Chronic obstructive pulmonary disease | Infections | Adults | Children | Middle ear | INFECTIOUS DISEASES | 7-VALENT PNEUMOCOCCAL VACCINE | PROTECTED SPECIMEN BRUSH | MULTIPLEX PCR | MICROBIOLOGY | IMMUNOLOGY | CHRONIC LUNG-DISEASE | ACUTE MAXILLARY SINUSITIS | OBSTRUCTIVE PULMONARY-DISEASE | MUCOSAL ANTIBODY-RESPONSE | ACUTE OTITIS-MEDIA | BACTERIAL-COLONIZATION | BRANHAMELLA-CATARRHALIS | Moraxellaceae Infections - epidemiology | United States - epidemiology | beta-Lactam Resistance | Pulmonary Disease, Chronic Obstructive - microbiology | Humans | Child, Preschool | Moraxella (Branhamella) catarrhalis - enzymology | Moraxellaceae Infections - microbiology | Infant | Moraxella (Branhamella) catarrhalis - cytology | Moraxella (Branhamella) catarrhalis - drug effects | beta-Lactamases - biosynthesis | Pulmonary Disease, Chronic Obstructive - epidemiology | Respiratory Tract Infections - microbiology | Young Adult | Animals | Bacterial Vaccines - immunology | Adult | Respiratory Tract Infections - epidemiology | Moraxella (Branhamella) catarrhalis - isolation & purification | Child | Respiratory tract infections | Care and treatment | Lung diseases, Obstructive | Causes of | Physiological aspects | Development and progression | Branhamella catarrhalis | Identification and classification
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 08/2011, Volume 55, Issue 8, pp. 3845 - 3853
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
ANTIBIOTICS | IGD-BINDING PROTEIN | PATHOGEN | EPITHELIAL-CELLS | MECHANISM | PSEUDOMONAS-AERUGINOSA | VITRONECTIN | BRANHAMELLA-CATARRHALIS | SURFACE | RESISTANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | Microscopy, Electron, Transmission | Bacterial Outer Membrane Proteins | Streptococcus pneumoniae - drug effects | Haemophilus influenzae - drug effects | Moraxella (Branhamella) catarrhalis - enzymology | Anti-Bacterial Agents - metabolism | Moraxella (Branhamella) catarrhalis - drug effects | Amoxicillin - metabolism | Blotting, Western | Moraxella (Branhamella) catarrhalis - metabolism | Flow Cytometry | Amoxicillin - pharmacology | Anti-Bacterial Agents - pharmacology | beta-Lactamases - metabolism | Enzymes | Flow cytometry | Pathogens | Adhesins | Immunomodulation | Outer membranes | Antibodies | Chronic infection | Membrane vesicles | Phospholipids | Survival | Western blotting | Lipooligosaccharides | Transmission electron microscopy | Antibiotics | Amoxicillin | Minimum inhibitory concentration | Respiratory tract diseases | Chronic obstructive pulmonary disease | Children | Colonization | Mechanisms of Resistance | Basic Medicine | Medical and Health Sciences | Microbiology in the medical area | Mikrobiologi inom det medicinska området | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper
Journal Article
Journal Article
by Jacobs, Michael R and Felmingham, David and Appelbaum, Peter C and Grüneberg, Reuben N and Kariuki, S and Klugman, K and Urbášková, P and Hryniewicz, W and Sidorenko, S.V and Upková, H and Theuretzbacher, U and Verhaegen, J and Lemozy, J and Dabernat, H and Goldstein, F and Weber, M and Roussel-Delvallez, M and Jehl, F and Grimm, H and Seewald, M and Mauch, H and Giamarellou, H and Schito, G.C and Stobberingh, E.E and Cristino, J.-M and Smyth, E and Gilleece, A and Fenelon, L and Liñares, J and Bille, J and Felmingham, D and Wing Hong, S and Yamaguchi, K and Kono, S and Inoue, M and Kaku, M and Yeo, M and Lin, R and Keller, N and Shibl, A.M and Mendes, C and Sifuentes-Osornio, J and Quiñones, F and Espinosa, L.E and Alvarez, G and Ma.Hinojosa, R and Tinoco, J.C and Ojeda, F and Grover, B and Gamble, S and Bay, M and Lamb, D and Munroe, S and Teskie, G and Wong, P and Cyprian, S and Cleary, T and Rivera, M and Watkins, C and Phillips, H and Prince, D and Walker, S and Beard, M and Carey, R and Droege, B and Tjhio, J and Denys, G and Cheek, R and Munier, G and Cato, B and Eppling, W and Cosmidis, D and DeMarco, D and McDermott, L and Schwartz, D and Welty, M and VanEnk, R and Loomis, J and McClure, L and Temme, L and Matthey, S and Hostetter, M and Buck, L and Overturf, G and Cammarata, R and Jenkins, S and Rosenstein, L and DiPersio, J.R and Jacobs, M and Hogan, C and Rourke, B and Kaufmann, L and Griffin, J and Smith, B and Brown, L and Cavagnolo, B and Lee, N and Mann, L and Korgenski, K and Alexander Project Grp and Alexander Project Group
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 08/2003, Volume 52, Issue 2, pp. 229 - 246
Objectives: The Alexander Project is a continuing surveillance study, begun in 1992, examining the susceptibility of pathogens involved in adult... 
Moraxella catarrhalis | Antimicrobial resistance | Surveillance | Community-acquired respiratory tract infection | Haemophilus influenzae | Streptococcus pneumoniae | INFECTIOUS DISEASES | MICROBIOLOGY | IN-VITRO SUSCEPTIBILITY | HAEMOPHILUS-INFLUENZAE | community-acquired respiratory tract infection | BACTERIAL PATHOGENS | PHARMACODYNAMIC PARAMETERS | STREPTOCOCCUS-PNEUMONIAE | antimicrobial resistance | RESISTANCE | BETA-LACTAM ANTIBIOTICS | MULTICENTER SURVEILLANCE | PNEUMOCOCCAL PNEUMONIA | PHARMACOLOGY & PHARMACY | AMOXICILLIN-CLAVULANATE | surveillance | Streptococcus pneumoniae - drug effects | Haemophilus influenzae - drug effects | Humans | Moraxella (Branhamella) catarrhalis - pathogenicity | Respiratory Tract Infections - drug therapy | Moraxella (Branhamella) catarrhalis - drug effects | Haemophilus influenzae - isolation & purification | Respiratory Tract Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Streptococcus pneumoniae - isolation & purification | Streptococcus pneumoniae - pathogenicity | Community-Acquired Infections - drug therapy | Internationality | Drug Resistance, Bacterial - physiology | Anti-Bacterial Agents - pharmacology | Haemophilus influenzae - pathogenicity | Moraxella (Branhamella) catarrhalis - isolation & purification | Community-Acquired Infections - microbiology | Population Surveillance - methods
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2016, Volume 60, Issue 6, pp. 3662 - 3668
Solithromycin, a fourth-generation macrolide (a fluoroketolide with enhanced activity against macrolide-resistant bacteria due to interaction with three... 
UNITED-STATES | PNEUMOCOCCAL VACCINE | SEROTYPES | CEM-101 | STREPTOCOCCUS-PNEUMONIAE | INHIBITION | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | Streptococcus pneumoniae - growth & development | United States - epidemiology | Community-Acquired Infections - epidemiology | Ketolides - pharmacology | Streptococcus - growth & development | Haemophilus influenzae - drug effects | Humans | Moraxella (Branhamella) catarrhalis - drug effects | Streptococcus - drug effects | Microbial Sensitivity Tests | Streptococcus pneumoniae - isolation & purification | Community-Acquired Infections - drug therapy | Streptococcus - isolation & purification | Macrolides - pharmacology | Moraxella (Branhamella) catarrhalis - isolation & purification | Bacterial Infections - microbiology | Haemophilus influenzae - growth & development | Latin America - epidemiology | Streptococcus pneumoniae - drug effects | Staphylococcus aureus - isolation & purification | Bacterial Infections - drug therapy | Europe - epidemiology | International Cooperation | Moraxella (Branhamella) catarrhalis - growth & development | Azithromycin - pharmacology | Haemophilus influenzae - isolation & purification | Triazoles - pharmacology | Asia - epidemiology | Epidemiological Monitoring | Bacterial Infections - epidemiology | Anti-Bacterial Agents - pharmacology | Staphylococcus aureus - drug effects | Staphylococcus aureus - growth & development | Community-Acquired Infections - microbiology
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2013, Volume 57, Issue 1, pp. 637 - 639
Journal Article
Journal Article
International Journal of Biological Macromolecules, ISSN 0141-8130, 10/2018, Volume 118, Issue Pt B, pp. 1747 - 1762
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 3/2009, Volume 63, Issue 3, pp. 511 - 519
Journal Article
15.